 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
CollabRx to Become Publicly Traded Company Following Acquisition by Tegal
July 03, 2012
CollabRx to Become Publicly Traded Company Following Acquisition by Tegal
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic
May 10, 2013 / ProteoMonitor - Theranostics Health to Launch HER Signaling Assay, Marking Firm's First Commercial Test Release
May 3, 2013 / ProteoMonitor - Verisante Highlights Data Backing Lung Cancer Dx, Preps Skin Cancer Dx for Year-End Launch
November 30, 2012 / ProteoMonitor - MDx/CDx Focus: Enzo Launches Lung Cancer Dx; Zelboraf Survival Data; Caris' Tumor Profiling Service
November 14, 2012 / Pharmacogenomics Reporter - Study Finds Genetic Testing Not Leading to Increased Use of Healthcare Services
May 17, 2012 / GenomeWeb Daily News